Related Experiment Videos
Infantile alpha 1 antitrypsin deficiency: a case report
Insights
Alpha 1 Antitrypsin Deficiency is a rare metabolic disorder causing severe liver and lung disease in infants. This case study details its pathophysiology, genetics, diagnosis, treatment, and nursing care strategies.
Area of Science:
- Metabolic disorders
- Genetics
- Pediatric medicine
Background:
- Alpha 1 Antitrypsin Deficiency (AATD) is a genetic disorder that can lead to severe liver and lung disease.
- Early-onset AATD in infancy is uncommon, presenting significant diagnostic and management challenges.
Observation:
- This case study focuses on an infant diagnosed with AATD before one year of age.
- The infant presented with substantial liver and pulmonary complications, highlighting the aggressive nature of early-onset disease.
Findings:
- The article elucidates the pathophysiology and genetic basis of Alpha 1 Antitrypsin Deficiency.
- Diagnostic approaches and current treatment strategies for infant AATD are comprehensively reviewed.
Implications:
- Understanding AATD pathophysiology and genetics is crucial for early diagnosis and intervention in infants.
- Effective nursing care, guided by diagnoses such as altered nutrition and ineffective airway clearance, is vital for managing AATD patients.
Abstract:
Using a case study format, the authors describe an infant with an unusual metabolic disorder, Alpha 1 Antitrypsin Deficiency. It is rare to find an infant in whom such significant liver and pulmonary disease develops before his first birthday. In this article the authors describe the pathophysiology, genetics, diagnosis, and treatment of this disorder. The nursing diagnoses alteration in nutrition, alteration in skin integrity, ineffective airway clearance, and potential for ineffective family coping are the framework used to describe the nursing care.